Denials · August 19, 2026

Stopping Timely Filing Denials in Dermatology

Timely filing denials in dermatology stem from unbilled charge bottlenecks like pending pathology and unsigned notes. Implement an escalation workflow to capture revenue before windows close.

By Michael Brennan · Vice President, Payer RelationsMedically-coded review by David Coleman, CPBPublished Last reviewed 5 min read

Timely filing denials are permanent revenue losses that cannot be written off as contractual adjustments or appealed without strict proof of prior submission. In high-volume dermatology practices, these write-offs rarely happen because a billing team forgot to submit an entire clearinghouse batch. They happen because individual encounters stall in complex sub-workflows—pending pathology results, unreviewed biopsy addenda, missing prior authorizations for biologics, or unverified secondary insurance policies—until the payer's filing window quietly expires.

Stopping timely filing write-offs requires an operational system that escalates unbilled charges before deadlines approach, shifting the burden from reactive denial management to proactive workqueue control.

The Operational Bottlenecks Unique to Dermatology

Dermatology encounters carry distinct clinical dependencies that frequently delay charge capture. When billing teams wait for clean, finalized records without active aging triggers, claims sit indefinitely in intermediate statuses.

  • Pending Pathology Reports: Biopsies, shaves, and excisions cannot be coded accurately without the dermatopathology gross and microscopic diagnosis. If an accession number is delayed or an outside lab takes weeks to return a report, the clinical note remains open and the charge remains unbilled.
  • Mohs and Complex Closures: Multi-stage Mohs micrographic surgery or complex repairs often require detailed operative notes, exact measurements in square centimeters, and defect site documentation. Clinicians falling behind on charting leave high-dollar surgical claims stalled in provider review workqueues.
  • Buy-and-Bill and Biologics: Specialty medications, patch testing panels, and photodynamic therapy (PDT) require verified pre-authorizations and exact J-codes or NDC units. If the administrative team identifies a discrepancy after service delivery, the claim often sits in limbo while staff attempt to back-verify authorization details.
  • Superbill and EHR Interface Drops: Unmapped provider templates, duplicate patient charts, or missing billing provider NPI assignments prevent clean interface transmissions from the EHR to the practice management (PM) system, masking missing claims from standard charge entry queues.

Understanding Payer Filing Clocks and Deadlines

Timely filing windows vary significantly across the dermatology payer mix. Relying on Medicare's standard one-year window creates a false sense of security that results in severe commercial losses.

Commercial payers (such as Aetna, Cigna, and UnitedHealthcare) frequently enforce filing windows ranging from 90 to 180 days from the date of service. Medicaid managed care organizations (MCOs) often enforce aggressive 90-day limits. Furthermore, when a primary payer adjudicates and leaves a balance, secondary payers enforce secondary filing windows that tick from the date of the primary remittance advice (ERA/EOB), not the original date of service.

If a primary claim is rejected at the clearinghouse level and never reaches the payer's processing system, the clock does not stop. Clearinghouse rejection reports that are not cleared within 24 to 48 hours directly feed future timely filing denials.

Building an Unbilled Charge Escalation Protocol

To prevent unbilled charges from aging out, dermatology practices must establish automated aging tiers within their practice management system. Escalation rules must assign clear operational ownership at each milestone.

`` +-----------------------------------------------------------------------+ | UNBILLED CHARGE ESCALATION WORKFLOW | +-----------------------------------------------------------------------+ | Day 0-5: Standard Processing | | * Provider completes chart; pathology pending. | +-----------------------------------------------------------------------+ | v +-----------------------------------------------------------------------+ | Day 6-10: Level 1 Escalation (Billing Specialist) | | * Daily clearinghouse rejection resolution. | | * Outreach to pathology lab for delayed histology reports. | +-----------------------------------------------------------------------+ | v +-----------------------------------------------------------------------+ | Day 11-20: Level 2 Escalation (Clinical/Provider) | | * Flag unsigned operative notes and missing Mohs closure details. | | * Resolve missing J-code/NDC units on biologic claims. | +-----------------------------------------------------------------------+ | v +-----------------------------------------------------------------------+ | Day 21-30+: Level 3 Escalation (Practice Manager / Lead) | | * Audit all charges approaching 30+ days unbilled. | | * Priority push for tight-window payers (Medicaid MCOs, 90-day plans)| +-----------------------------------------------------------------------+ ``

Tier 1: Days 1 to 5 (Standard Charge Scrubbing)

The encounter is completed, pathology is linked, and standard front-end scrubbing rules validate demographic data, policy active dates, and basic CPT/HCPCS modifiers (such as modifier 25 on E/M visits with same-day procedures or modifier 59/XS on multiple destructions).

Tier 2: Days 6 to 10 (Administrative and Lab Escalation)

Any encounter lacking a finalized charge enters an administrative workqueue. The billing lead reviews missing pathology reports, tracks down outside accession logs, and reviews clearinghouse front-end rejection reports to ensure 100% of batched claims generated a valid 277CA acceptance acknowledgment.

Tier 3: Days 11 to 20 (Clinical Escalation)

Incomplete provider documentation escalates directly to the clinical lead or practice manager. Providers receive a daily dashboard of unsigned surgical encounters, unclosed charts, and missing excision dimensions. Unresolved claims are prioritized based on payer filing strictness (e.g., commercial and Medicaid MCOs take precedence over traditional Medicare).

Tier 4: Days 21 to 30 (Hard Stop Review)

Any claim unbilled at 21 days is flagged as an imminent risk. The practice manager must review the blocking issue (such as an unresolvable coordination of benefits issue or missing retro-authorization) and execute an emergency filing or paper submission with proof of delivery to protect the filing window.

Concrete Workflow Controls to Implement This Week

Practices can immediately plug revenue leaks by adopting strict daily and weekly operational habits:

  • Reconcile Appointments to Superbills Daily: Run an end-of-day reconciliation report comparing checked-in appointments against generated charges. Every biopsy, patch test application, excision, and office visit must have a corresponding charge line or a documented reason for postponement.
  • Audit the 277CA Acknowledgment File: Never assume a batch sent by your billing software was received by the payer. Require billers to clear clearinghouse rejections daily and confirm electronic data interchange (EDI) acceptance reports.
  • Establish an Outside Pathology Tracking Log: Maintain a centralized log of all tissue specimens sent to third-party reference laboratories. If a pathology report is not received within 5 business days, administrative staff must contact the lab before the charge ages into a secondary queue.
  • Implement a Secondary Claim Sweep: Set automated triggers for primary payments that cross over with patient responsibility. If an electronic crossover fails, secondary claims must drop to billers within 48 hours of primary ERA posting to comply with tight secondary filing windows.
  • Maintain Strict Proof-of-Filing Logs: For claims submitted via paper, clearinghouse manual portals, or payer direct-data entry (DDE), archive EDI transaction numbers, certified mail receipts, and batch confirmation reports in the patient’s financial file.

When older balances have already slipped past billing deadlines or unbilled encounters have stacked up across prior months, deploying dedicated dermatology accounts receivable recovery protocols is necessary to audit root causes, overturn improper denials with clearinghouse documentation, and recover stranded revenue.

Preserving Revenue Through Tight Operational Timelines

Preventing timely filing write-offs is fundamentally an exercise in operational discipline rather than post-denial appeals. By identifying charge capture delays early, monitoring outside pathology dependencies, and actively escalating stalled charts, dermatology practices protect their baseline revenue and eliminate preventable financial losses.

If your practice is struggling with rising timely filing adjustments or unbilled charge backlogs, contact us for a free dermatology claims audit to identify workflow gaps and secure your revenue cycle.

Frequently asked questions

What documentation serves as valid proof of timely filing during an appeal?

Payer-accepted proof includes Electronic Data Interchange (EDI) 277CA acceptance reports, clearinghouse transaction confirmations showing acceptance by the payer's gateway, or certified mail receipts with corresponding claim details. Internal practice management generation logs or clearinghouse submission-only reports without payer acknowledgment are typically rejected.

How does timely filing apply to secondary insurance claims in dermatology?

Most secondary payers require claims to be submitted within their standard timely filing window (e.g., 90 to 180 days) starting from the date listed on the primary payer's Explanation of Benefits (EOB) or Electronic Remittance Advice (ERA), rather than the original date of service. Failure to bill the secondary immediately after primary posting is a frequent source of timely filing write-offs.

Can a dermatology practice bill an excision before receiving the pathology report to beat a filing deadline?

Clinicians should not submit the surgical charge without the pathology report because the diagnosis dictates the final CPT code (e.g., benign excision series 11400-11446 vs. malignant excision series 11600-11646) and the medical necessity for the margins taken. Instead, practices must establish a 5-day lab tracking protocol to pull reports before filing deadlines are threatened.

How often should dermatology billing teams audit their unbilled charge queues?

Unbilled encounters should trigger their first operational review between 6 and 10 days post-service. At 11 to 20 days, unbilled charts must escalate to clinical leadership for documentation completion, ensuring all claims are cleanly submitted well before the shortest commercial payer windows (typically 90 days) expire.

Primary sources

Coding and coverage rules change. Verify against the source before you bill.

Find your leaked revenue. Free dermatology claims audit — results in 5 business days.